Patient satisfaction following transition from the original to the new formulation of subcutaneous interferon beta-la in relapsing multiple sclerosis: a randomized, two-arm, open-label, Phase IIIb study.

Autor: Camu, William, Hadjout, Karim, Latour, Sabine, Pöhlau, Dieter, Masri, Said
Zdroj: Patient Preference & Adherence; 2010, Vol. 4, p127-133, 7p
Databáze: Complementary Index